Late Breaking Abstract - ETD001: A long-acting inhaled ENaC blocker, is well tolerated in humans
P. Russell (Falmer, United Kingdom), K. Woodward (Falmer, United Kingdom), J. Charlwood (Falmer, United Kingdom), R. White (Loughborough, United Kingdom), D. Wilkes (London, United Kingdom), H. Danahay (Falmer, United Kingdom), D. Morris (Falmer, United Kingdom)
Source: International Congress 2022 – Late-breaking abstracts in airway disease
Session: Late-breaking abstracts in airway disease
Session type: Thematic Poster
Number: 4175
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Russell (Falmer, United Kingdom), K. Woodward (Falmer, United Kingdom), J. Charlwood (Falmer, United Kingdom), R. White (Loughborough, United Kingdom), D. Wilkes (London, United Kingdom), H. Danahay (Falmer, United Kingdom), D. Morris (Falmer, United Kingdom). Late Breaking Abstract - ETD001: A long-acting inhaled ENaC blocker, is well tolerated in humans. 4175
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|